ArticleFrontiers in bioengineering and biotechnology2020

Assessment of Growth Reduction of Five Clinical Pathogens by Injectable S53P4 Bioactive Glass Material Formulations.

Eline G J Thijssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.